[HTML][HTML] Development of Mcl-1 inhibitors for cancer therapy
A Negi, PV Murphy - European journal of medicinal chemistry, 2021 - Elsevier
The myeloid leukemia cell differentiation protein (Mcl-1) is an anti-apoptotic protein of the B-
cell lymphoma 2 (Bcl-2) family, which regulates cellular apoptosis. Mcl-1 expression plays a …
cell lymphoma 2 (Bcl-2) family, which regulates cellular apoptosis. Mcl-1 expression plays a …
A comprehensive overview of β-carbolines and its derivatives as anticancer agents
B Luo, X Song - European Journal of Medicinal Chemistry, 2021 - Elsevier
Abstract β-Carboline alkaloids are a family of natural and synthetic products with structural
diversity and outstanding antitumor activities. This review summarizes research …
diversity and outstanding antitumor activities. This review summarizes research …
Catalytic and enantioselective control of the C–N stereogenic axis via the Pictet–Spengler reaction
A Kim, A Kim, S Park, S Kim, H Jo, KM Ok… - Angewandte …, 2021 - Wiley Online Library
An unprecedented example of a chiral phosphoric acid‐catalyzed atroposelective Pictet–
Spengler reaction of N‐arylindoles is reported. Highly enantioenriched N‐aryl‐tetrahydro‐β …
Spengler reaction of N‐arylindoles is reported. Highly enantioenriched N‐aryl‐tetrahydro‐β …
β-Carboline-based molecular hybrids as anticancer agents: A brief sketch
JP Soni, Y Yeole, N Shankaraiah - RSC Medicinal Chemistry, 2021 - pubs.rsc.org
Cancer is a huge burden on the healthcare system and is foremost cause of mortality across
the globe. Among various therapeutic strategies, chemotherapy plays an enormous role in …
the globe. Among various therapeutic strategies, chemotherapy plays an enormous role in …
Natural and synthetic β-carboline as a privileged antifungal scaffolds
JK Dai, WJ Dan, JB Wan - European Journal of Medicinal Chemistry, 2022 - Elsevier
The discovery of antifungal agents with novel structure, broad-spectrum, low toxicity, and
high efficiency has been the focus of medicinal chemists. Over the past decades, β-carboline …
high efficiency has been the focus of medicinal chemists. Over the past decades, β-carboline …
Ascidian toxins with potential for drug development
DJ Watters - Marine Drugs, 2018 - mdpi.com
Ascidians (tunicates) are invertebrate chordates, and prolific producers of a wide variety of
biologically active secondary metabolites from cyclic peptides to aromatic alkaloids. Several …
biologically active secondary metabolites from cyclic peptides to aromatic alkaloids. Several …
Metal complexes of β-carboline: Advances in anticancer therapeutics
The platinum-based complexes were the first anticancer metallotherapeutics to emerge and
since their discovery several other coordination compounds consisting of transition metal …
since their discovery several other coordination compounds consisting of transition metal …
An overview of piperazine scaffold as promising nucleus for different therapeutic targets
A Sharma, S Wakode, F Fayaz… - Current …, 2020 - ingentaconnect.com
Piperazine scaffolds are a group of heterocyclic atoms having pharmacological values and
showing significant results in pharmaceutical chemistry. Piperazine has a flexible core …
showing significant results in pharmaceutical chemistry. Piperazine has a flexible core …
Design, synthesis, anti-cancer evaluation and binding mode studies of benzimidazole/benzoxazole linked β-carboline derivatives
R Sireesha, R Sreenivasulu, C Chandrasekhar… - Journal of Molecular …, 2021 - Elsevier
A new series of benzimidazole/benzoxazole linked β-carbolines (9a-j) were rationally
designed and synthesized by combining two different anti-cancer fragments. The new hybrid …
designed and synthesized by combining two different anti-cancer fragments. The new hybrid …
Discovery of a copper-based Mcl-1 inhibitor as an effective antitumor agent
Myeloid cell leukemia 1 (Mcl-1), which belongs to the Bcl-2 family of prosurvival proteins, is
a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been …
a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been …